4.6 Article

Macrophages-stimulated PRMT1-mediated EZH2 methylation promotes breast cancer metastasis

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2020.10.037

Keywords

Tumor-associated macrophages; Cancer metastasis; IL-6; PRMT1; EZH2; Post-translational modifications

Funding

  1. National Natural Science Foundation of China [81802637]
  2. Natural Science Foundation of Jiangsu Province [BK20190989]
  3. China Postdoctoral Science Foundation [2019M651971]
  4. Natural Science Foundation of Jiangsu Province Universities [18KJB310016]
  5. Research Foundation of Xuzhou Medical University [D2018020]
  6. Xuzhou City Science and Technology Plan Project [KC19065]
  7. Jiangsu Provincial Key Medical Discipline, the Project of Invigorating Health Care through Science, Technology and Education [ZDXKA2016014]

Ask authors/readers for more resources

Tumor-associated macrophages (TAMs) are important monocytes in the breast cancer microenvironment. They facilitate the distant metastasis of breast cancer. However, the detailed mechanisms of TAMderived cancer metastasis have not been clearly elucidated. Here, we demonstrate that PRMT1 is essential for TAM-mediated breast cancer cell migration and metastasis. TAMs increase EZH2 stability by stimulating PRMT1-mediated meR342-EZH2 formation through the secretion of interleukin-6 (IL-6) cytokine. Moreover, high expression levels of TAMs are positively correlated with PRMT1, meR342-EZH2, and EZH2 expression in breast cancer patients. Our study presents a novel mechanism of TAM-induced breast cancer metastasis via the IL-6-PRMT1-meR342-EZH2 axis. (C) 2020 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available